NASDAQ:CRMETSX:COM CARDIOME ANNOUNCES XYDALBATM TREATMENT AND PATIENT EXPERIENCE PRESENTATIONS AT THE 2017 NATIONAL OPAT CONFERENCE Plenary Symposium Features Three Experts Discussing Clinical Use Vancouver, Canada, December 11, 2017 - Cardiome Pharma Corp. (NASDAQ:CRME / TSX:COM), a revenue-generating, specialty pharmaceutical company focused on commercializing patent-protected hospital drugs, today announced a plenary sponsored symposium at the 2017 National Outpatient Parenteral Antimicrobial Therapy (OPAT) Conference, hosted by the British Society for Antimicrobial Chemotherapy, taking place December 11-12, 2017 in Birmingham, UK. The Company-sponsored plenary symposium, titled,...
|
